Mini-Organs shed light on why some kids respond better to gut drug

This study looks at why children with short bowel syndrome (a rare condition where part of the intestine is missing) respond differently to the drug teduglutide. Researchers will grow tiny, lab-made versions of the children's intestines (called organoids) from tissue samples taken during routine surgery. They will then treat these mini-intestines with teduglutide in a dish to see how they change. The goal is to find biological clues that explain why some children benefit more than others, which could lead to more personalized treatment in the future. No new treatments are given to the children themselves.